Seize the day, investors! Feast your eyes on three stocks showcasing robust momentum and earning potential on this fine June 18th:
Prepare for a wild ride with Mercury General Corporation (MCY). This auto insurance giant boasts a Zacks Rank #1 and has seen its Zacks Consensus Estimate for current year earnings surge by a whopping 18.6% over the past 60 days.
Mercury General Corporation Price and Consensus
Mercury General Corporation has outpaced the S&P 500, enjoying a 7.5% surge in share value over the last quarter. With a solid Momentum Score of A, this company is firing on all cylinders.
Mercury General Corporation Price
Next up, we have ASM International NV (ASMIY). A leading semiconductor device equipment provider with a Zacks Rank #1, its current year earnings estimate has skyrocketed by 24.3% in the past 60 days.
ASM International NV Price and Consensus
ASM International NV has been a force to reckon with, boasting a 25.1% gain in share price over the last three months, while the S&P 500 lagged behind. The company’s Momentum Score of B speaks volumes about its potential.
ASM International NV Price
Lastly, embrace the strength of Byrna Technologies Inc. (BYRN), a non-lethal defense technology firm. Sporting a Zacks Rank #1, it has seen its current year earnings estimate shoot up by 7.1% over the last 60 days.
Byrna Technologies Inc. Price and Consensus
Byrna Technologies has been a true powerhouse, notching an impressive 74.1% surge in share value over the last half-year, leaving the S&P 500 in the dust. Its Momentum Score of B indicates a journey worth embarking on.
Byrna Technologies Inc. Price
For a full list of top-ranked stocks, take a peek here.
Test your wits further by delving into the nuances of the Momentum score and how it is calculated here.
Where will the market head next…
Under a Biden or Trump Victory?
Curious minds ponder these questions. Since 1950, election years have proved to be a boon for stocks, regardless of the political tide. Dive into Zacks’ Special Report to uncover 5 stocks poised for gains—the ultimate bipartisan bonanza!
1. A medical marvel has catapulted an astonishing +11,000% in the last decade and a half.
2. A rental dynamo is leaving competition in the dust.
3. An energy juggernaut eyes a hefty 25% dividend increment.
4. An aerospace gem secures a potential $80 billion triumph.
5. A tech titan lays the foundation for colossal plants right here in the U.S.
Snatch up the free Special Report now for an exhilarating read!
For more investment insights, grab your hands on the latest recommendations from Zacks Investment Research here.
Seek more financial wisdom? Allow Zacks Investment Research to satiate your intellectual hunger.
